Springetts treatment for pharmaceuticals group

Springetts has developed a new corporate identity for Norwegian pharmaceutical and research company Nutripharma. The revamp comes as the client prepares to launch a range of new consumer brands across Europe.

Springetts has developed a new corporate identity for Norwegian pharmaceutical and research company Nutripharma.

The revamp comes as the client prepares to launch a range of new consumer brands across Europe. These include weight loss and cholesterol reduction products, described by the pharmaceuticals group as “ground breaking”. The London consultancy is also developing individual brand identities for the ranges.

While the corporate brand will appear on Nutripharma’s consumer products, it will also be used as a business-to-business communication device, as the company takes an active role in developing brands and ranges for sale or licensing to other pharmaceuticals companies.

Springetts describes Nutripharma as a virtual company, as it has no manufacturing capabilities of its own.

“This corporate brand will probably not be front of mind for the consumers, but will be very important in getting the company’s pure pharmaceutical products on doctors’ prescription lists – and into the over-the-counter pharmacy,” says Springetts managing director Peter Green.

Latest articles